Stock Market Live June 4, 2026: S&P 500 (SPY) Fall as Broadcom Sinks

Investing

AbbVie : ABBV

All AbbVie Articles

579 Articles

Lee Jackson | Apr 30, 2026 at 7:49 AM EDT

Here Are Thursday’s Top Wall Street Analyst Research Calls: AbbVie, Equinix, GE Healthcare, Kratos Defense, Meta Platforms, Oneok, Palantir Technologies, Wingstop, and More

Pre-Market Stock Futures: Futures are trading higher this morning after a messy Wednesday trading session that saw all major indices…

John Seetoo | Apr 25, 2026 at 6:35 AM EDT

Healthcare CEF Insiders Are Quietly Buying While 60% of Distributions Return Capital

Income investors shopping the healthcare aisle often land on Gabelli Healthcare & WellnessRx Trust (NYSE:GRX), a closed-end fund managed by…

Vandita Jadeja | Apr 23, 2026 at 4:04 PM EDT

These 5 Stocks Pay You Even When You’re Sleeping

Market volatility in 2026 has reminded investors that earned income alone is fragile. When tariff fears rattle equities and economic…

David Beren | Apr 21, 2026 at 3:34 PM EDT

GDV’s 6.1% Yield Faces a Hidden Test in 2026 Small-Cap Downturn

Gabelli Dividend & Income Trust (NYSE:GDV) trades near $29 and pays a $0.15 monthly distribution, up from $0.11 per month…

David Moadel | Apr 21, 2026 at 10:30 AM EDT

Canaccord Calls AbbVie a Core Holding With a $262 Target: Is This Biopharma’s Most Durable Compounder?

One of Wall Street’s top firms just made the bull case for AbbVie (NYSE:ABBV | ABBV Price Prediction) stock, initiating…

Vandita Jadeja | Apr 20, 2026 at 10:37 AM EDT

Why I Can’t Stop Buying AbbVie Stock

AbbVie (NYSE:ABBV | ABBV Price Prediction) has attracted persistent buying interest, and every pullback has drawn in value-focused investors. The…

Vandita Jadeja | Apr 17, 2026 at 10:22 AM EDT

AbbVie vs. Pfizer: One Pharma Dividend Has a Moat — The Other Is Praying for a Pipeline Hit

AbbVie (NYSE:ABBV | ABBV Price Prediction) and Pfizer (NYSE:PFE) both reported fourth quarter earnings in early February. AbbVie posted record…

David Moadel | Apr 7, 2026 at 9:58 AM EDT

AbbVie Gets JPMorgan Buying Opportunity Call With $260 Price Target Amid Competitive Concerns

AbbVie (NYSE:ABBV | ABBV Price Prediction) stock has pulled back 12% over the past month, sliding to around $204. JPMorgan…

Vandita Jadeja | Apr 6, 2026 at 12:15 PM EDT

High Yield vs. Sustainable Growth: Why AbbVie’s Dividend Beats Pfizer’s Despite the Lower Payout

Pharmaceutical companies AbbVie (NYSE:ABBV | ABBV Price Prediction) and Pfizer (NYSE:PFE) both reported fourth-quarter earnings in early February, revealing two…

Lee Jackson | Apr 2, 2026 at 8:10 AM EDT

The 5 Safest Dividend Aristocrats Are Perfect For Retirees Needing Growth & Income

With inflation back in the economic picture, simply getting a dependable income stream may not be the best strategy for…

John Seetoo | Mar 27, 2026 at 11:49 AM EDT

Why Income Investors Keep VTV as a Core Portfolio Anchor in a Turbulent 2026

Retirees and income-focused investors have long used Vanguard Value ETF (NYSEARCA:VTV | VTV Price Prediction) as a core portfolio anchor,…

Michael Williams | Mar 26, 2026 at 2:32 PM EDT

VHT Lagged the Market by 57 Points Over 5 Years. Here Is Why Long-Term Investors Still Hold It

Healthcare spending doesn’t stop during recessions. That structural reality is the core argument for owning Vanguard Health Care ETF (NYSEARCA:VHT…

John Seetoo | Mar 25, 2026 at 1:30 PM EDT

VIG Returned 223% Over 10 Years and Still Costs Almost Nothing

A 1.5% yield sounds unimpressive until you realize the dividend check doubles roughly every seven years. That is the premise…

Chris MacDonald | Mar 20, 2026 at 10:02 AM EDT

The Only 3 Growth ETFs I Would Buy and Hold Through Any Market

Growth investing has had a choppy start to 2026. The major growth benchmarks are down in the low single digits…

Austin Smith | Mar 20, 2026 at 8:02 AM EDT

JP Morgan’s Dividend Leaders ETF Sounds Good, But The Yield Underwhelms

JPMorgan Dividend Leaders ETF (NYSEARCA:JDIV) launched in September 2024 with an appealing premise: a curated portfolio of global dividend leaders.…

1 2 3 4 … 39

AbbVie : ABBV

All AbbVie Articles

Here Are Thursday’s Top Wall Street Analyst Research Calls: AbbVie, Equinix, GE Healthcare, Kratos Defense, Meta Platforms, Oneok, Palantir Technologies, Wingstop, and More

Healthcare CEF Insiders Are Quietly Buying While 60% of Distributions Return Capital

These 5 Stocks Pay You Even When You’re Sleeping

GDV’s 6.1% Yield Faces a Hidden Test in 2026 Small-Cap Downturn

Canaccord Calls AbbVie a Core Holding With a $262 Target: Is This Biopharma’s Most Durable Compounder?

Why I Can’t Stop Buying AbbVie Stock

AbbVie vs. Pfizer: One Pharma Dividend Has a Moat — The Other Is Praying for a Pipeline Hit

AbbVie Gets JPMorgan Buying Opportunity Call With $260 Price Target Amid Competitive Concerns

High Yield vs. Sustainable Growth: Why AbbVie’s Dividend Beats Pfizer’s Despite the Lower Payout

The 5 Safest Dividend Aristocrats Are Perfect For Retirees Needing Growth & Income

Why Income Investors Keep VTV as a Core Portfolio Anchor in a Turbulent 2026

VHT Lagged the Market by 57 Points Over 5 Years. Here Is Why Long-Term Investors Still Hold It

VIG Returned 223% Over 10 Years and Still Costs Almost Nothing

The Only 3 Growth ETFs I Would Buy and Hold Through Any Market

JP Morgan’s Dividend Leaders ETF Sounds Good, But The Yield Underwhelms

Stock Market Live June 4, 2026: S&P 500 (SPY) Fall as Broadcom Sinks

Live Nasdaq Composite: Semiconductor Stumble Tests the Market’s AI Conviction

Live: Will Rubrik Crush Q1 Earnings Tonight and Continue Its 33% 1-Month Rally?

AMD Is Up 55% in a Month and Trouncing Intel. Should Intel Stockholders Switch to AMD Now?

The Space Economy ETF That Turned $10,000 Into $26,500 in One Year

The $43,000-a-Year 401(k) Withdrawal That Keeps a $1.4 Million Retiree in the 12% Bracket for Life

The $43,000-a-Year 401(k) Withdrawal That Keeps a $1.4 Million Retiree in the 12% Bracket for Life

Suze Orman's Counterintuitive Advice: Leave Your Marriage to Protect $400,000 in Retirement Savings

AMD Is Up 55% in a Month and Trouncing Intel. Should Intel Stockholders Switch to AMD Now?

Live: Will Rubrik Crush Q1 Earnings Tonight and Continue Its 33% 1-Month Rally?

AbbVie : ABBV

All AbbVie Articles

Here Are Thursday’s Top Wall Street Analyst Research Calls: AbbVie, Equinix, GE Healthcare, Kratos Defense, Meta Platforms, Oneok, Palantir Technologies, Wingstop, and More

Healthcare CEF Insiders Are Quietly Buying While 60% of Distributions Return Capital

These 5 Stocks Pay You Even When You’re Sleeping

GDV’s 6.1% Yield Faces a Hidden Test in 2026 Small-Cap Downturn

Canaccord Calls AbbVie a Core Holding With a $262 Target: Is This Biopharma’s Most Durable Compounder?

Why I Can’t Stop Buying AbbVie Stock

AbbVie vs. Pfizer: One Pharma Dividend Has a Moat — The Other Is Praying for a Pipeline Hit

AbbVie Gets JPMorgan Buying Opportunity Call With $260 Price Target Amid Competitive Concerns

High Yield vs. Sustainable Growth: Why AbbVie’s Dividend Beats Pfizer’s Despite the Lower Payout

The 5 Safest Dividend Aristocrats Are Perfect For Retirees Needing Growth & Income

Why Income Investors Keep VTV as a Core Portfolio Anchor in a Turbulent 2026

VHT Lagged the Market by 57 Points Over 5 Years. Here Is Why Long-Term Investors Still Hold It

VIG Returned 223% Over 10 Years and Still Costs Almost Nothing

The Only 3 Growth ETFs I Would Buy and Hold Through Any Market

JP Morgan’s Dividend Leaders ETF Sounds Good, But The Yield Underwhelms

Stock Market Live June 4, 2026: S&P 500 (SPY) Fall as Broadcom Sinks

Live Nasdaq Composite: Semiconductor Stumble Tests the Market’s AI Conviction

Live: Will Rubrik Crush Q1 Earnings Tonight and Continue Its 33% 1-Month Rally?

AMD Is Up 55% in a Month and Trouncing Intel. Should Intel Stockholders Switch to AMD Now?

The Space Economy ETF That Turned $10,000 Into $26,500 in One Year

The $43,000-a-Year 401(k) Withdrawal That Keeps a $1.4 Million Retiree in the 12% Bracket for Life

Featured Reads

The $43,000-a-Year 401(k) Withdrawal That Keeps a $1.4 Million Retiree in the 12% Bracket for Life

Suze Orman's Counterintuitive Advice: Leave Your Marriage to Protect $400,000 in Retirement Savings